Net Debt Summary of AstraZeneca PLC

AstraZeneca PLC's latest annual net debt in 2023 was 22.78 Billion USD , down -1.23% from previous year.
AstraZeneca PLC's latest quarterly net debt in 2024 Q1 was 26.71 Billion USD , up 17.24% from previous quarter.
AstraZeneca PLC reported annual net debt of 23.06 Billion USD in 2022, down -5.67% from previous year.
AstraZeneca PLC reported annual net debt of 24.45 Billion USD in 2021, up 94.87% from previous year.
AstraZeneca PLC reported quarterly net debt of 26.71 Billion USD for 2024 Q1, up 17.24% from previous quarter.
AstraZeneca PLC reported quarterly net debt of 24.17 Billion USD for 2023 Q2, down -4.34% from previous quarter.

Annual Net Debt Chart of AstraZeneca PLC (2023 - 1990)

Historical Annual Net Debt of AstraZeneca PLC (2023 - 1990)

Year	Net Debt	Net Debt Growth
2023	22.78 Billion USD	-1.23%
2022	23.06 Billion USD	-5.67%
2021	24.45 Billion USD	94.87%
2020	12.54 Billion USD	-2.41%
2019	12.85 Billion USD	-9.97%
2018	14.28 Billion USD	-1.39%
2017	14.48 Billion USD	22.84%
2016	11.79 Billion USD	33.78%
2015	8.81 Billion USD	96.59%
2014	4.48 Billion USD	286.8%
2013	1.15 Billion USD	-55.58%
2012	2.6 Billion USD	48.49%
2011	1.75 Billion USD	219.28%
2010	-1.47 Billion USD	-206.05%
2009	1.38 Billion USD	-81.63%
2008	7.56 Billion USD	-18.59%
2007	9.28 Billion USD	257.98%
2006	-5.88 Billion USD	-55.64%
2005	-3.77 Billion USD	-35.03%
2004	-2.79 Billion USD	19.97%
2003	-3.49 Billion USD	9.1%
2002	-3.84 Billion USD	-1165.73%
2001	360.86 Million USD	304.75%
2000	-176.24 Million USD	-125.56%
1999	689.66 Million USD	-1.54%
1998	700.47 Million USD	4.37%
1997	671.16 Million USD	-16.08%
1996	799.73 Million USD	-21.34%
1995	1.01 Billion USD	225.17%
1994	312.68 Million USD	-36.33%
1993	491.09 Million USD	-83.64%
1992	3 Billion USD	1.65%
1991	2.95 Billion USD	-11.82%
1990	3.34 Billion USD	0.0%

Year	Net Debt	Net Debt Growth
2024 Q2	26.61 Billion USD	-0.35%
2024 Q1	26.71 Billion USD	17.24%
2023 Q2	24.17 Billion USD	-4.34%
2023 Q1	25.27 Billion USD	9.56%
2023 Q3	23.7 Billion USD	-1.94%
2023 Q4	22.78 Billion USD	-3.89%
2023 FY	22.78 Billion USD	-1.23%
2022 Q3	24.84 Billion USD	0.53%
2022 Q4	23.06 Billion USD	-7.15%
2022 Q1	25.33 Billion USD	3.62%
2022 FY	23.06 Billion USD	-5.67%
2022 Q2	24.71 Billion USD	-2.47%
2021 Q2	11.92 Billion USD	-4.55%
2021 Q4	24.45 Billion USD	-1.58%
2021 FY	24.45 Billion USD	94.87%
2021 Q3	24.84 Billion USD	108.29%
2021 Q1	12.49 Billion USD	-0.41%
2020 Q1	15.16 Billion USD	17.93%
2020 FY	12.54 Billion USD	-2.41%
2020 Q4	12.54 Billion USD	-12.05%
2020 Q3	14.26 Billion USD	1.37%
2020 Q2	14.07 Billion USD	-7.18%
2019 Q3	14.19 Billion USD	-0.6%
2019 Q2	14.27 Billion USD	-18.15%
2019 FY	12.85 Billion USD	-9.97%
2019 Q1	17.44 Billion USD	22.13%
2019 Q4	12.85 Billion USD	-9.39%
2018 FY	14.28 Billion USD	-1.39%
2018 Q2	16.68 Billion USD	-0.95%
2018 Q3	17.49 Billion USD	4.82%
2018 Q1	16.84 Billion USD	16.34%
2018 Q4	14.28 Billion USD	-18.36%
2017 Q1	14.27 Billion USD	21.06%
2017 Q4	14.48 Billion USD	4.83%
2017 Q2	14.48 Billion USD	1.49%
2017 Q3	13.81 Billion USD	-4.63%
2017 FY	14.48 Billion USD	22.84%
2016 Q1	12.88 Billion USD	46.19%
2016 Q4	11.79 Billion USD	-19.21%
2016 Q2	13.66 Billion USD	6.05%
2016 FY	11.79 Billion USD	33.78%
2016 Q3	14.59 Billion USD	6.8%
2015 FY	8.81 Billion USD	96.59%
2015 Q1	7.37 Billion USD	64.55%
2015 Q3	6.86 Billion USD	-2.49%
2015 Q4	8.81 Billion USD	28.36%
2015 Q2	7.04 Billion USD	-4.55%
2014 Q2	5.11 Billion USD	-14.18%
2014 Q3	4.78 Billion USD	-6.57%
2014 Q4	4.48 Billion USD	-6.21%
2014 FY	4.48 Billion USD	286.8%
2014 Q1	5.96 Billion USD	414.32%
2013 Q1	2.97 Billion USD	14.03%
2013 Q3	2.82 Billion USD	32.24%
2013 Q4	1.15 Billion USD	-58.93%
2013 FY	1.15 Billion USD	-55.58%
2013 Q2	2.13 Billion USD	-28.27%
2012 Q3	4.89 Billion USD	191.95%
2012 Q4	2.6 Billion USD	-46.71%
2012 Q1	3.05 Billion USD	73.65%
2012 FY	2.6 Billion USD	48.49%
2012 Q2	1.67 Billion USD	-45.03%
2011 Q3	-411 Million USD	-1225.81%
2011 Q4	1.75 Billion USD	527.49%
2011 FY	1.75 Billion USD	219.28%
2011 Q1	384 Million USD	120.8%
2011 Q2	-31 Million USD	-108.07%
2010 Q1	3.19 Billion USD	141.29%
2010 FY	-1.47 Billion USD	-206.05%
2010 Q4	-1.84 Billion USD	-306.03%
2010 Q3	896 Million USD	111.79%
2010 Q2	-7.59 Billion USD	-337.51%
2009 FY	1.38 Billion USD	-81.63%
2009 Q4	-7.74 Billion USD	-308.84%
2009 Q3	3.71 Billion USD	-19.78%
2009 Q2	4.62 Billion USD	-36.87%
2009 Q1	7.32 Billion USD	-3.12%
2008 Q1	12.08 Billion USD	30.07%
2008 FY	7.56 Billion USD	-18.59%
2008 Q2	10.53 Billion USD	-12.82%
2008 Q3	9.83 Billion USD	-6.66%
2008 Q4	7.56 Billion USD	-23.08%
2007 Q1	-4.42 Billion USD	24.81%
2007 FY	9.28 Billion USD	257.98%
2007 Q2	10.44 Billion USD	336.33%
2007 Q3	10.96 Billion USD	4.99%
2007 Q4	9.28 Billion USD	-15.32%
2006 Q3	-4.55 Billion USD	7.91%
2006 FY	-5.88 Billion USD	-55.64%
2006 Q4	-5.88 Billion USD	-29.12%
2006 Q1	-5.88 Billion USD	-996.34%
2006 Q2	-4.94 Billion USD	15.9%
2005 FY	-3.77 Billion USD	-35.03%
2005 Q1	-3.77 Billion USD	-3329.06%
2005 Q2	-4.13 Billion USD	-9.53%
2005 Q3	-3.15 Billion USD	23.73%
2005 Q4	656 Million USD	120.79%
2004 Q3	245 Million USD	181.67%
2004 Q2	-300 Million USD	31.35%
2004 FY	-2.79 Billion USD	19.97%
2004 Q1	-437 Million USD	-57.19%
2004 Q4	117 Million USD	-52.24%
2003 Q3	- USD	100.0%
2003 FY	-3.49 Billion USD	9.1%
2003 Q4	-278 Million USD	0.0%
2003 Q2	-3.61 Billion USD	0.0%
2003 Q1	- USD	-100.0%
2002 Q2	-3.45 Billion USD	0.0%
2002 Q3	- USD	100.0%
2002 FY	-3.84 Billion USD	-1165.73%
2002 Q4	118 Million USD	0.0%
2002 Q1	- USD	-100.0%
2001 Q4	360.86 Million USD	0.0%
2001 Q1	- USD	100.0%
2001 Q2	-3.35 Billion USD	0.0%
2001 Q3	- USD	100.0%
2001 FY	360.86 Million USD	304.75%
2000 FY	-176.24 Million USD	-125.56%
2000 Q1	- USD	-100.0%
2000 Q2	-1.76 Billion USD	0.0%
2000 Q3	- USD	100.0%
2000 Q4	-176.24 Million USD	0.0%
1999 Q2	-588 Million USD	0.0%
1999 Q3	-2.66 Billion USD	-353.74%
1999 Q4	689.66 Million USD	125.85%
1999 FY	689.66 Million USD	-1.54%
1998 Q2	1.01 Billion USD	0.0%
1998 FY	700.47 Million USD	4.37%
1998 Q4	700.47 Million USD	0.0%
1997 FY	671.16 Million USD	-16.08%
1997 Q4	671.16 Million USD	0.0%
1996 FY	799.73 Million USD	-21.34%
1996 Q4	799.73 Million USD	0.0%
1995 Q4	1.01 Billion USD	0.0%
1995 Q2	393.9 Million USD	0.0%
1995 FY	1.01 Billion USD	225.17%
1994 Q4	312.68 Million USD	0.0%
1994 FY	312.68 Million USD	-36.33%
1993 Q4	491.09 Million USD	0.0%
1993 FY	491.09 Million USD	-83.64%
1992 FY	3 Billion USD	1.65%
1991 FY	2.95 Billion USD	-11.82%
1990 FY	3.34 Billion USD	0.0%

Peer Net Debt Comparison of AstraZeneca PLC

Name	Net Debt	Net Debt Difference
Amgen Inc.	53.66 Billion USD	57.551%
Biogen Inc.	6.28 Billion USD	-262.292%
Gilead Sciences, Inc.	18.9 Billion USD	-20.527%
MIRA Pharmaceuticals, Inc.	-4.59 Million USD	495629.641%
Scilex Holding Company	124.54 Million USD	-18192.624%
Scilex Holding Company	124.54 Million USD	-18192.624%

Global Stocks Search

AstraZeneca PLC (AZN)

Net Debt Summary of AstraZeneca PLC

Annual Net Debt Chart of AstraZeneca PLC (2023 - 1990)

Historical Annual Net Debt of AstraZeneca PLC (2023 - 1990)

Peer Net Debt Comparison of AstraZeneca PLC